Eaton Vance Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$5.41M Buy
87,352
+656
+0.8% +$40.6K 0.01% 755
2022
Q2
$6.92M Sell
86,696
-5,227
-6% -$417K 0.01% 713
2022
Q1
$9.67M Buy
91,923
+54,813
+148% +$5.77M 0.01% 700
2021
Q4
$4M Sell
37,110
-590
-2% -$63.6K ﹤0.01% 836
2021
Q3
$4.05M Buy
37,700
+700
+2% +$75.3K 0.01% 770
2021
Q2
$3.47M Buy
37,000
+8,343
+29% +$781K ﹤0.01% 877
2021
Q1
$2.64M Buy
28,657
+1,494
+6% +$138K ﹤0.01% 910
2020
Q4
$1.99M Buy
27,163
+15
+0.1% +$1.1K ﹤0.01% 927
2020
Q3
$2.11M Hold
27,148
﹤0.01% 825
2020
Q2
$1.51M Sell
27,148
-270
-1% -$15K ﹤0.01% 873
2020
Q1
$812K Buy
27,418
+199
+0.7% +$5.89K ﹤0.01% 964
2019
Q4
$985K Buy
27,219
+108
+0.4% +$3.91K ﹤0.01% 995
2019
Q3
$738K Buy
27,111
+111
+0.4% +$3.02K ﹤0.01% 1039
2019
Q2
$650K Hold
27,000
﹤0.01% 1056
2019
Q1
$714K Hold
27,000
﹤0.01% 996
2018
Q4
$528K Hold
27,000
﹤0.01% 986
2018
Q3
$529K Hold
27,000
﹤0.01% 1015
2018
Q2
$447K Sell
27,000
-27,000
-50% -$447K ﹤0.01% 1026
2018
Q1
$766K Buy
54,000
+27,000
+100% +$383K ﹤0.01% 1020
2017
Q4
$394K Hold
27,000
﹤0.01% 1004
2017
Q3
$342K Hold
27,000
﹤0.01% 1009
2017
Q2
$320K Hold
27,000
﹤0.01% 1003
2017
Q1
$399K Sell
27,000
-171
-0.6% -$2.53K ﹤0.01% 935
2016
Q4
$440K Buy
27,171
+171
+0.6% +$2.77K ﹤0.01% 878
2016
Q3
$490K Hold
27,000
﹤0.01% 846
2016
Q2
$445K Hold
27,000
﹤0.01% 839
2016
Q1
$447K Hold
27,000
﹤0.01% 804
2015
Q4
$585K Buy
+27,000
New +$585K ﹤0.01% 777